Lord, Abbett & Co
AVNR

Lord, Abbett & Co’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Lord, Abbett & Co’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,563,789
Closed -$30.6M – 1054
2014
Q3 		$30.6M Buy
+2,563,789
New +$17.5M 0.08% 365

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lord, Abbett & Co's AVNR Position: Q4 2014 in Review

Lord, Abbett & Co sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 2,563,789 shares — an estimated $30.6M sold.

Lord, Abbett & Co first reported a position in AVNR in Q3 2014 and held it in 1 quarter. The position peaked at $30.6M in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Lord, Abbett & Co reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Lord, Abbett & Co sold 2,563,789 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $30.6M.
  • Lord, Abbett & Co first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 1 quarter.
  • Lord, Abbett & Co's AVANIR PHARMACEUTICALS, INC CL A position peaked at $30.6M in Q3 2014.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Lord, Abbett & Co's 13F filing for Q4 2014, filed 13 Feb 2015.